Wordt geladen...
MON-461 Drug Repurposing to Explore Novel Treatment for Cushing Disease
Cushing Disease (CD), caused by adrenocorticotropic hormone (ACTH)-secreting pituitary adenomas, leads to excess production of adrenal-derived cortisol. Current medical treatments for CD include adrenal steroidogenesis inhibitors (Ketoconazole, Metyrapone), the somatostatin receptor ligand Pasireoti...
Bewaard in:
| Gepubliceerd in: | J Endocr Soc |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Endocrine Society
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6550912/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-461 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|